Health
‘Significant challenges’ ahead as vaccine rollout recalibrates – Sydney Morning Herald
NSW Health has said new advice regarding use of the AstraZeneca vaccine in people under 50 will cause “significant challenges” for the Australian rollout.
NSW Health has said new advice regarding the use of the AstraZeneca vaccine in people under 50 will cause significant challenges for the Australian rollout.
The ministry stopped delivering first doses of the AstraZeneca vaccine to eligible people aged under 50 following advice issued by vaccine advisory group ATAGI on Thursday night that they should be given the Pfizer vaccine.
More people will need to receive the Pfizer vaccine following advice from vaccine advisory group ATAGI.Credit:Edwina Pickles
…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025
-
Business24 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
-
Noosa News20 hours agoMan dies after stabbing in inner-city unit